共 188 条
[11]
Bonaglia L(2008)Nonparametric estimation from incomplete observations Ann Oncol 19 920-1312
[12]
Marini G(2009)Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the firstline treatment of patients with metastatic colorectal cancer. EORTC study 40015 Anticancer Res 29 91-10
[13]
Iannelli A(2003)Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts J Clin Oncol 21 1307-1448
[14]
Cortinovis D(1989)Randomized multicenter phase II trial of two different schedules of capecitabine plus oxaliplatin as first-line treatment in advanced colorectal cancer Control Clin Trials 10 1-216
[15]
Ferrario E(2003)Optimal two-stage designs for phase II clinical trials Ann Oncol 14 1442-1802
[16]
Beretta E(2000)Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study J Natl Cancer Inst 92 205-63
[17]
Lambiase A(2008)New guidelines to evaluate the response to treatment in solid tumours J Clin Oncol 26 1797-1197
[18]
Buzzoni R(2009)Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer Ann Oncol 20 61-undefined
[19]
Cassidy J(2004)Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up Br J Cancer 90 1190-undefined
[20]
Tabernero J(undefined)Oral capecitabine undefined undefined undefined-undefined